AN2 Therapeutics, Inc. (ANTX) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by AN2 Therapeutics, Inc. on May 22, 2025. The company is incorporated in Delaware and trades on The Nasdaq Global Select Market under the symbol ANTX. As of the record date (March 24, 2025), there were 30,098,720 shares of common stock outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders representing 79.50% of outstanding shares attended the meeting, constituting a quorum. Two proposals were voted upon:
- Proposal 1: Election of Class III Directors
- Eric Easom: Elected with 13,983,213 votes for; 6,541,893 votes withheld.
- Stephanie Wong: Elected with 10,584,641 votes for; 9,940,465 votes withheld.
- Joseph Zakrzewski: Elected with 10,928,200 votes for; 9,596,906 votes withheld.
- Broker Non-Votes: 3,403,334 for all nominees.
- Proposal 2: Ratification of Independent Auditor
- PricewaterhouseCoopers LLP was ratified for the fiscal year ending December 31, 2025.
- Votes For: 23,736,942
- Votes Against: 47,413
- Abstentions: 144,085
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to disclose the certified results of the shareholder vote.
Investor Verification Checklist
- Verify the significant number of votes withheld for directors Stephanie Wong and Joseph Zakrzewski, which exceeded 40% of the votes cast for each.
- Confirm the total number of shares outstanding (30,098,720) against the most recent 10-Q or 10-K filings to ensure no subsequent capital changes.
- Review the definitive proxy statement (Schedule 14A filed April 10, 2025) for detailed biographies of the elected directors and the rationale behind the voting results.